Shorts

Deprescribing and Assessing Pharmacology Over Time

Developments in Psychedelics for Depression

Why Traditional Grief Support Isn't Enough

Forging a New Path for Treatment-Resistant Depression

AI-Related Job Loss and Psychiatric Impacts

A Turning Point in Psychedelics

Dangers of Fentanyl: Addiction and Overdose

Patient Connection: The Skill of Listening

A 3-Pronged Approach to ADHD Diagnosis

Depression and Ketamine: Increased Neuroplasticity

Interpersonal Therapy Effective for Perinatal Depression

Interactions of GLP-1s and Eating Disorders

Decriminalization vs Legalization: Psychedelic Policy Roadmap

SAMSHA Funding Reinstated by Congress: A Clinician's Perspective

Treating Athlete Pain, Pressure & Drugs

Cognitive Control for Craving Management

The Power of Collaborative Research

What We Love About Psychiatry

DSM-6: Putting Profit Over Patient Safety?

The 4 Stages of Gambling Addiction

Championship-Level Care in Psychiatry

Latest in Psychedelic Trials for PTSD

78% Higher Long COVID Risk: The Mental Health Connection

Treating Comorbid Personality Disorders

Morning Coffee and Updates: A New and Improved DSM?

DSM Updates: The 4 New Domains Recommended

Adult vs Child ADHD: What the Data Reveals

Pressure Is a Privilege: A New Look at Mental Health

Could Depression Be Treated Like an Immune Disease?

ADHD Medication Risks in Pregnancy